Azmacort and Propulsid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Azmacort (triamcinolone acetonide) and Propulsid (cisapride monohydrate). Common drug interactions include weight increased among females and chest pain among males.
The phase IV clinical study analyzes what interactions people have when they take Azmacort and Propulsid. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.
What is Azmacort?
Azmacort has active ingredients of triamcinolone acetonide. It is often used in asthma. eHealthMe is studying from 3,612 Azmacort users. Check the latest studies of Azmacort.
What is Propulsid?
Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.
47 people who take Azmacort and Propulsid together, and have interactions are studied.

What are the common drug interactions of Azmacort and Propulsid, by gender? *:
female:
- Weight increased
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Back pain
- Blood creatinine increased
- Chronic obstructive airways disease
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dysuria (painful or difficult urination)
- Fatigue (feeling of tiredness)
male:
- Chest pain
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Abdominal pain
- Abdominal pain upper
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Aortic valve stenosis (narrowing of the aortic valve)
- Arrhythmia (irregular heartbeat)
- Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
- Arthropathy
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
What are the common drug interactions of Azmacort and Propulsid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Hallucination (an experience involving the perception of something not present)
10-19:
n/a
20-29:
n/a
30-39:
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Oesophageal disorder (disease of oesophagus)
- Respiratory disorder (respiratory disease)
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Oedema lower limb (fluid collection in tissue of lower leg)
- Dyspepsia (indigestion)
- Influenza like illness
- Malaise (a feeling of general discomfort or uneasiness)
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
40-49:
- Chest pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Arrhythmia (irregular heartbeat)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetic retinopathy (damage to the retina caused by complications of diabetes)
- Fear of disease
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Gastric bypass
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
50-59:
- Sweating increased (excess sweating)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Abdominal pain
- Cough
- Hypertrophy (increase in the volume of an organ or tissue due to the enlargement of its component cells)
- Pulmonary congestion (congestion in the lungs)
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Adult respiratory distress syndrome (type of lung (pulmonary) failure)
- Anaemia (lack of blood)
- Ascites (accumulation of fluid in the abdominal cavity)
60+:
- Dyspnoea (difficult or laboured respiration)
- Chest pain
- Chronic obstructive airways disease
- Cough
- Fatigue (feeling of tiredness)
- Haemoglobin decreased
- Heart rate increased
- Nausea (feeling of having an urge to vomit)
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Upper respiratory tract infection
* Approximation only. Some reports may have incomplete information.
Do you take Azmacort and Propulsid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Azmacort and Propulsid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Azmacort:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Propulsid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Azmacort and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Propulsid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on triamcinolone acetonide and cisapride monohydrate (the active ingredients of Azmacort and Propulsid, respectively), and Azmacort and Propulsid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Postmenopause and drugs of ingredients of ciprofloxacin hydrochloride - 4 seconds ago
- Kidney Infection and drugs of ingredients of modafinil - 8 seconds ago
- Could Micardis cause Brain Natriuretic Peptide Increased? - 11 seconds ago
- Indigestion and Skin Exfoliation - 18 seconds ago
- Drug interactions of Mycophenolate Mofetil and Dasatinib - 21 seconds ago
- Could Aimovig cause Cellulitis Aggravated? - 28 seconds ago
- Oxybutynin Chloride and Pneumonia for Women aged 40-49 - 29 seconds ago
- Oxybutynin Chloride and Pneumonitis for Women aged 40-49 - 29 seconds ago
- Oxybutynin Chloride and Bronchopneumonia for Women aged 40-49 - 29 seconds ago
- Oxybutynin Chloride and Community-Acquired Pneumonia for Women aged 40-49 - 30 seconds ago